Translate page

Save the date: 16th Annual John Goldman Conference on CML: Biology and Therapy   in Philadelphia on September 4-7, 2014 

Folie1

Topics:

  • Special lectures
  • Saturday Parallel Symposium for Clinicians: Diagnosis and Monitoring
  • Workshops for non-clinical scientists
  • Brief oral communications selected from submitted abstracts
  • Clinical and Biology Poster Walks
  • Satellite symposia

Deadline for abstracts is June 7th, 2014

Presentation of data at this conference will not jeopardize acceptance of any abstracts for the ASH conference that follows in December

 

To register and for further information got the the ESH website

Or contact nicolas.jaillard@unv-paris-diderot.fr

 

List of abstracts presented at the 15th International Conference on CML now available

The list of abstracts from the 15th International Conference on CML: Biology and Therapy that took place in Estoril, Portugal, from September 26-29, 2013 is now available for download.

The conference, co-sponsored by the iCMLf and the European School of Haematology (ESH) focused on the latest findings on biology and clinical research and current therapeutic approaches. Over 540 people from 43 different countries attended this premier CML meeting.

 

iCMLf Forum 2013 at ASH – sharing best practice to improve CML management in emerging regionsiCMLf Forum 2013 Audience

We are delighted that over 100 physicians from 21 countries attended this year´s iCMLf Forum for Physicians from Emerging Economic Regions. This annual event is held during the American Society of Hematology meeting.

15th International Conference on CML: Biology and Therapy – updates on biology and clinical research and therapy in CML

The 15th International Conference on CML: Biology and Therapy took place in Estoril,
John Goldman iCMLf-ESH meeting 2013Portugal, from September 26-29, 2013. This leading international CML meeting was again co-sponsored by the iCMLf and the European School of Haematology (ESH). The conference being chaired by John M Goldman (UK), J. Cortes and Timothy P. Hughes (Australia) again focused on the latest up-dates on biology and clinical research and current therapeutic approaches. 

CML Africa workshop 2013 on November 20th in Durban, South Africa                             - continuous education and training opportunities are key 

The iCMLf was pleased to support the second CML Africa meeting held in Durban on the 20th November. “CML Africa meeting 2013”, was a training workshop on CML for healthcare professionals from the African continent. Training was organised by the MAX Foundation and supported by Novartis Oncology, the iCMLf and other sponsors.

CML Africa enables collaboration, training and networking between leading CML researchers in the US and their African counterparts. The workshop was designed as a satellite session of the African Organization for Research and Training in Cancer (AORTIC) conference. International delegates from 20 African countries attended the meeting, among them regional CML clinicians, local healthcare professionals and representatives of patient organizations.

This year’s CML Africa meeting provided information and training on the use of new tyrosine kinase inhibitors to improve the management of CML patients in Africa. The program included specific presentations and Q&A sessions on drug application, switching therapy, monitoring of residual disease as well managing pregnancy for CML patients. 

 

Click here to see the full story on the Max Foundation website www.themaxfoundation.org/news/FullStory.aspx?storyid=261 

 

As an organisation dedicated to improving the lives of patients with CML around the world the iCMLf is a proud sponsor of this initiative in Africa.